Forward Citations = 16

Loading Chart...

8 inventors (with patents filed for the assignee):

Jukka Hiltunen (2 out of 11 patents)

Anders Holmberg (2 out of 3 patents)

Christer Halldin (1 out of 7 patents)

4. Sten Nilsson (1 out of 1 patent)

5. Jan-Erik Westlin (1 out of 1 patent)

6. Tuomo Nikula (1 out of 1 patent)

7. Lars Farde (1 out of 1 patent)

8. Christian Foged (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6569841 - Ion exchange tumor targeting (IETT) (2003-05-27),

2. 6455025 - Polysaccharide-peptide derivatives (2002-09-24),

3. 6365125 - Process for the production of radioiodinated neuroreceptor agents (2002-04-02),

4. 6015544 - Process for producing radiolabelled benzodiazepine receptor agents and (2000-01-18),

Company Overview

Map Medical Technologies Oy is a Finnish company specializing in developing innovative medical devices and technology solutions for healthcare professionals and patients. With a focus on precision, efficiency, and quality, Map Medical Technologies is committed to improving the standard of care in medical diagnostics and treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#1 in Tikkakoski

#642 in Finland

Tikkakoski, Finland

Map Medical Technologies Oy

Forward Citations = 16

8 inventors:

Jukka Hiltunen (2 out of 11 patents)

Anders Holmberg (2 out of 3 patents)

Christer Halldin (1 out of 7 patents)

4. Sten Nilsson (1 out of 1 patent)

5. Jan-Erik Westlin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Map Medical Technologies Oy. Retrieved from https://idiyas.com/company/map-medical-technologies-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]